GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » YoY Rev. per Sh. Growth

Big Pharma Split (TSX:PRM) YoY Rev. per Sh. Growth : 1,940.24% (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Big Pharma Split's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was 1,940.24%.

Big Pharma Split's Revenue per Share for the six months ended in Jun. 2024 was C$1.51.

Big Pharma Split YoY Rev. per Sh. Growth Historical Data

The historical data trend for Big Pharma Split's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split YoY Rev. per Sh. Growth Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial -39.98 -80.04 603.38 -40.85 -89.59

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.12 -56.69 -104.54 -46.64 1,940.24

Big Pharma Split YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Big Pharma Split's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.256-2.459)/ | 2.459 |
=-89.59 %

Big Pharma Split's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=(Revenue per Share (Q: Jun. 2024 )-Revenue per Share (Q: Jun. 2023 )) / | Revenue per Share (Q: Jun. 2023 )) |
=(1.509--0.082)/ | -0.082 |
=1,940.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TSXV:AIVC TSXV:MIVO NEOE:JPEG TSXV:CLCO XCNQ:SOL TSXV:CSOC.A TSX:XTD XCNQ:TLP.UN TSXV:ELC XCNQ:LFG BLK KKR BX TSX:BAM OSTO:INVE A TSX:BN APO LSE:III AMP ARES
Traded in Other Exchanges
XN4:Germany PRM.PR.A.PFD:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Executives
Michael Kovacs Director, Senior Officer